| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/15/2011 | US20110224183 16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity |
| 09/15/2011 | US20110224179 Medicament and method of diagnosis |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110223233 Microfabricated nanopore device for sustained release of therapeutic agent |
| 09/15/2011 | US20110223214 Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/14/2011 | EP2365085A1 Growth hormone fusion protein |
| 09/14/2011 | EP2364708A2 Pharmaceutical composition comprising a C1C-2 channel opener |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN102186874A New NO releasing steroids derivatives |
| 09/14/2011 | CN102186829A Bridged tetrahydronaphthalene derivatives |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102178685A Application of taurochenodeoxycholic acid in protection of adrenal gland function |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017574 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | CA2514614C Vitamin d3 lactone derivatives |
| 09/13/2011 | CA2508952C Tetrahydroquinoline derivatives and their use as follicle stimulating hormone receptor modulators |
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/13/2011 | CA2452606C Tetrahydroquinoline derivatives |
| 09/09/2011 | WO2011109787A1 Methods of administering insulinotropic peptides |
| 09/09/2011 | WO2011109448A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011108762A1 Prophylactic and/or ameliorating agent for insulin resistance |
| 09/09/2011 | WO2011108690A1 Alkylamine derivative |
| 09/09/2011 | WO2011106991A1 One kind of complex molecules of protein polypeptide and application thereof |
| 09/09/2011 | CA2828041A1 Methods and compositions for treating or preventing symptoms of hormonal variations |
| 09/09/2011 | CA2791994A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 09/09/2011 | CA2791174A1 Alkylamine derivative |
| 09/08/2011 | US20110218225 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 09/08/2011 | US20110218214 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 09/08/2011 | US20110218213 Methods and Compositions for Treating or Preventing Symptoms of Hormonal Variations |
| 09/08/2011 | US20110218160 Arylalkylamine compound and process for preparing the same |
| 09/08/2011 | US20110218147 Activin-actriia antagonists for inhibiting germ cell maturation |
| 09/08/2011 | US20110217336 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
| 09/08/2011 | US20110217272 Treatment of radiation injury using placental stem cells |
| 09/08/2011 | US20110217271 Treatment of diseases or disorders using placental stem cells |
| 09/08/2011 | US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds |
| 09/07/2011 | EP2046737B1 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
| 09/07/2011 | CN102177137A 1-phenylpyrrole compounds |
| 09/07/2011 | CN102174065A Triazolyl containing pentacyclic triterpenoid derivatives and preparation method and medicinal application thereof |
| 09/07/2011 | CN101926826B Method for extracting active ingredients from sea horse |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101239125B Capable of improving endocrine function |
| 09/06/2011 | CA2670422C Spiroketone acetyl-coa carboxylase inhibitors |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2488642C Aryl carbonyl derivatives as glucokinase activators |
| 09/06/2011 | CA2415228C Treatment of bone diseases |
| 09/01/2011 | WO2011056390A3 Method of making an artificial micro-gland that is anisotropic |
| 09/01/2011 | WO2011056389A3 Method of making an artificial micro-gland using taxis |
| 09/01/2011 | US20110213032 Fatty acid c16: 1n7-palmitoleate a lipokine and biomarker for metabolic status |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212953 Polymorph Form II of Tanaproget |
| 09/01/2011 | US20110212890 Metastin derivative and use thereof |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212072 Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction |
| 09/01/2011 | US20110212052 Methods and compositions of treating and preventing autoimmune diseases |
| 09/01/2011 | CA2790703A1 Estrogen receptor ligands and methods of use thereof |
| 08/31/2011 | EP2073810B1 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection |
| 08/31/2011 | EP1523325B1 Methods and compositions for treating polycystic ovary syndrome |
| 08/31/2011 | EP1361869B1 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 08/31/2011 | CN1946387B Use of 4-hydroxy tamoxifen in treatment and prevention of benign breast disease |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166327A Preparation method of Chinese medicine for treating liver-stagnation spleen-deficiency hyperthyroidism |
| 08/31/2011 | CN102166326A Preparation method of traditional Chinese medicine for treating liver depression and kidney deficiency type hyperthyroidism |
| 08/31/2011 | CN102166325A Preparation method of Chinese medicine for treating hyperthyroidism |
| 08/31/2011 | CN102166311A Preparation method of Chinese medicine for treating spleen-deficiency sthenic liver-energy hyperthyroidism |
| 08/31/2011 | CN102166310A Preparation method of traditional Chinese medicine for treating liver and kidney Yin deficiency type hyperthyroidism |
| 08/31/2011 | CN102166309A Preparation method of traditional Chinese medicine for curing middle energizer intrinsic heat type hyperthyroidism |
| 08/31/2011 | CN101884794B Application of S100A16 gene in preparing medicaments for treating insulin resistance |
| 08/31/2011 | CN101395134B 17 beta hsd type 5 inhibitor |
| 08/31/2011 | CN101228135B Pyridazinone derivatives as thyroid hormone receptor agonists |
| 08/30/2011 | US8008333 Inducing ovulation; increasing response to follicle stimulating hormone |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/25/2011 | WO2011103202A2 Androgen receptor modulators and uses thereof |
| 08/25/2011 | WO2011103130A1 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/25/2011 | US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/25/2011 | US20110207679 Methods of treatment using il-16 antagonist peptides |
| 08/25/2011 | US20110206775 Preparation of inert pharmaceutical excipients for stabilizing unstable pharmaceutical ingredients |
| 08/25/2011 | US20110206739 Compositions and methods for the preparation of nanoemulsions |
| 08/25/2011 | US20110206663 Anti-Interferon-Alpha Antibodies |
| 08/25/2011 | US20110206633 Polymer conjugates of cd-np peptides |
| 08/25/2011 | US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 08/25/2011 | CA2789753A1 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/25/2011 | CA2787083A1 Androgen receptor modulators and uses thereof |
| 08/24/2011 | EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/24/2011 | EP2358369A1 Process for the preparation of substantially optically pure repaglinide and precursors thereof |
| 08/24/2011 | EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | CN102160889A Extract, composition, and use of overground part of hedychium coronarium koenig |
| 08/24/2011 | CN101361535B Compound pollen cream and preparation method thereof |
| 08/23/2011 | US8003629 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/23/2011 | US8003615 Stable vitamin B6 derivative |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/23/2011 | CA2449954C Dry powder inhalation system for transpulmonary administration |
| 08/23/2011 | CA2358107C Shelf-stable formulation of glucagon-like peptide-1 |